ARTICLE | Company News
Cleveland BioLabs cancer news
June 25, 2012 7:00 AM UTC
Cleveland BioLabs said Bioprocess Capital Ventures LLC, a Russian venture company, invested about $6 million into the companies' Incuron LLC JV (Moscow, Russia). Incuron was formed in 2009 to develop the biotech's portfolio of Curaxin compounds for cancer. Cleveland's stake in Incuron dropped from 75.8% to 59.81%. ...